SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (5694)11/22/1998 7:06:00 AM
From: Clive Roberts  Read Replies (1) of 6136
 
Thanks Richard. AGPH has been fun....Actually .....If you remember I got the tip for AGPH from my wife's gastroenterologist no less. During this time, my wife was severely ill from Crohns Disease, and (knowing nothing about biotech), I went in search of a solution. I found a small company called Centocor with a drug codenamed CA2 in a Phase 2 trial.....

Now on anecdotal evidence on newsgroups I figured Centocor might not just cure my wife, but was also a good buy (knowing nothing about stocks :>)). I suggested as much to the gastro (sounds a bit mercenary eh? ...wife writhing in agony, me discussing PE ratios with her doctor :>).......but he put me onto Agouron. So I put my dough into AGPH instead of CNTO. Two days later Centocor went from $9 to $30, because of FDA action on Reopro.

Still, I waited patiently for AGPH to appreciate not least because of your informed comments on misc.invest.stocks and the rest is history.

And ...for the record my wonderful wife is now in A1 health and a few weeks back gave birth to a beautiful baby girl. Centocor went on to successfully release Ca2 as Avakine.

Hope things are as fine with you as they are with me. The only downside is ....I still don't know much about nothing.:>)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News